Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Human Gene Therapy|February 20, 2025
Adeno-Associated Virus Gene Therapy Development: Early Planning and Regulatory Considerations to Advance the Platform Vector Gene Therapy ProgramRicha Madan Lomash, Jean Dehdashti, Oleg A Shchelochkov, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
The SARS-CoV-2 cytopathic effect is blocked with autophagy modulatorsKirill Gorshkov, Catherine Z Chen, Robert Bostwick, et al.
Biorxiv : the Preprint Server for Biology|August 26, 2020
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2Catherine Z Chen, Paul Shinn, Zina Itkin, et al.
Frontiers in Pharmacology|March 12, 2021
Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2Catherine Z Chen, Paul Shinn, Zina Itkin, et al.
Genes & Development|February 22, 2020
MDM2 and MDMX promote ferroptosis by PPARα-mediated lipid remodelingDivya Venkatesh, Nicholas A O'Brien, Fereshteh Zandkarimi, et al.
Nature Medicine|July 16, 2013
Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington's disease modelsSonia Marco, Albert Giralt, Milos M Petrovic, et al.
Neuron|August 15, 2009
Downregulation of NR3A-containing NMDARs is required for synapse maturation and memory consolidationAdam C Roberts, Javier Díez-García, Ramona M Rodriguiz, et al.
Science Translational Medicine|December 8, 2017
PPARδ activation by bexarotene promotes neuroprotection by restoring bioenergetic and quality control homeostasisAudrey S Dickey, Dafne N Sanchez, Martin Arreola, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2021
Application of niclosamide and analogs as small molecule inhibitors of Zika virus and SARS-CoV-2 infectionKhalida Shamim, Miao Xu, Xin Hu, et al.
Pageof 7